Molecular cloning, functional expression, and pharmacological characterization of 5-hydroxytryptamine3 receptor cDNA and its splice variants from guinea pig.

Polymerase chain reaction and rapid amplification of cDNA ends were used to isolate cDNAs encoding a 5-hydroxytryptamine3 (5-HT3) receptor subunit and its splice variants from guinea pig intestine. The amino acid sequence predicted from this cDNA is 81% homologous to the murine 5-HT3 receptor subunits cloned from NCB20 and N1E-115 cells. The splice variants code for two proteins differing by a deletion of six amino acids located in the large intracellular loop between transmembrane domains M3 and M4. For characterization, the cloned 5-HT3 cDNA was expressed in HEK 293 cells, and the electrophysiological and pharmacological properties of the recombinant ion/channel/receptor complex were investigated by patch clamping. Our data reveal that the cloned cDNAs code for guinea pig 5-HT3 receptors, which functionally assemble as homo-oligomers. The kinetic behavior of the ion channel and its sensitivity to several agonists and antagonists were markedly different from those of the cloned 5-HT3 receptors from mouse and human under similar experimental conditions. The agonists used were 5-hydroxytryptamine, 2-methyl-5-hydroxytryptamine, 1-phenylbiguanide (PBG), m-chlorophenylbiguanide, and the antagonists tropisetron and metoclopramide. In addition, 5-HT, PBG, and tropisetron were investigated through radioligand binding to isolated membranes. Compared with the human and murine 5-HT3 receptors, the guinea pig receptor showed prolonged desensitization kinetics. In addition, the guinea pig 5-HT3 receptor did not respond to the selective 5-HT3 receptor agonist PBG. Construction of chimeric receptors between guinea pig and human 5-HT3 receptor sequences localized the differences in desensitization kinetics to the carboxyl-terminal domain and the ligand binding site to the amino-terminal domain of the receptor protein. Molecular determinants of the PBG binding site of the human 5-HT3 receptor were localized to a 28-amino-acid spanning region adjacent to the M1 region.

[1]  L. Tecott,et al.  Nervous system distribution of the serotonin 5-HT3 receptor mRNA. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[2]  R. Myers,et al.  Primary structure and functional expression of the 5HT3 receptor, a serotonin-gated ion channel. , 1991, Science.

[3]  J. A. Peters,et al.  Cloning and functional expression of an apparent splice variant of the murine 5-HT3 receptor A subunit. , 1993, European journal of pharmacology.

[4]  Gavin Kilpatrick,et al.  The pharmacological characterization of 5‐HT3 receptors in three isolated preparations derived from guinea‐pig tissues , 1990, British journal of pharmacology.

[5]  R. Gralla,et al.  Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting. , 1981, The New England journal of medicine.

[6]  P. Kosmidis,et al.  Antiemetic efficacy of high-dose metoclopramide and dexamethasone in patients receiving cisplatin chemotherapy: a randomized trial. , 1992, Oncology.

[7]  J. Changeux,et al.  Chimaeric nicotinic–serotonergic receptor combines distinct ligand binding and channel specificities , 1993, Nature.

[8]  E. Melamed,et al.  Ondansetron for hallucinosis in advanced Parkinson's disease , 1993, The Lancet.

[9]  M. Kozak.  The scanning model for translation: an update , 1989, The Journal of cell biology.

[10]  J. Apud.  The 5-HT3 Receptor in Mammalian Brain: A New Target for the Development of Psychotropic Drugs? , 1993, Neuropsychopharmacology.

[11]  C. Gorman,et al.  Transient production of proteins using an adenovirus transformed cell line , 1990 .

[12]  S. Mochizuki,et al.  Molecular cloning of human 5-hydroxytryptamine3 receptor: heterogeneity in distribution and function among species. , 1995, Molecular pharmacology.

[13]  P. Blier,et al.  Functional characterization of a 5‐HT3 receptor which modulates the release of 5‐HT in the guinea‐pig brain , 1993, British journal of pharmacology.

[14]  D. Morris,et al.  Initiation codons within 5'-leaders of mRNAs as regulators of translation. , 1994, Trends in biochemical sciences.

[15]  M. Hamon,et al.  Developmental Changes in the Differential Expression of Two Serotonin 5‐HT3 Receptor Splice Variants in the Rat , 1995, Journal of neurochemistry.

[16]  M. Beato,et al.  Creating chimeric molecules by PCR directed homologous DNA recombination. , 1991, Nucleic Acids Research.

[17]  Gavin Kilpatrick,et al.  Inter-species variants of the 5-HT3 receptor. , 1992, Biochemical Society transactions.

[18]  M. Martres,et al.  Differentiation Alters the Expression of the Two Splice Variants of the Serotonin 5‐HT3 Receptor‐A mRNA in NG108‐15 Cells , 1995, Journal of neurochemistry.

[19]  F. Barrantes.  The Nicotinic Acetylcholine Receptor , 1998, Biotechnology Intelligence Unit.

[20]  C. A. Thomas,et al.  Molecular cloning. , 1977, Advances in pathobiology.

[21]  H. Betz.  Ligand-gated ion channels in the brain: The amino acid receptor superfamily , 1990, Neuron.

[22]  Gavin Kilpatrick,et al.  Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding , 1987, Nature.

[23]  E. Kawashima,et al.  Organization of the mouse 5-HT3 receptor gene and functional expression of two splice variants. , 1994, Brain research. Molecular brain research.

[24]  D Rodbard,et al.  Ligand: a versatile computerized approach for characterization of ligand-binding systems. , 1980, Analytical biochemistry.

[25]  L. Pinna.  Casein kinase 2: an 'eminence grise' in cellular regulation? , 1990, Biochimica et biophysica acta.

[26]  J. A. Peters,et al.  Recent advances in the electrophysiological characterization of 5-HT3 receptors. , 1992, Trends in pharmacological sciences.

[27]  R. Stroud,et al.  Nicotinic acetylcholine receptor superfamily of ligand-gated ion channels. , 1990, Biochemistry.

[28]  P. Sargent,et al.  The diversity of neuronal nicotinic acetylcholine receptors. , 1993, Annual review of neuroscience.

[29]  J. A. van Hooft,et al.  Phosphorylation controls conductance of 5-HT3 receptor ligand-gated ion channels. , 1995, Receptors & channels.

[30]  E. Barnard,et al.  Receptor classes and the transmitter-gated ion channels. , 1992, Trends in biochemical sciences.

[31]  P. Uetz,et al.  Organisation of the murine 5‐HT3 receptor gene and assignment tohuman chromosome 11 , 1994, FEBS letters.

[32]  Gavin Kilpatrick,et al.  The distribution of specific binding of the 5-HT3 receptor ligand [3H]GR65630 in rat brain using quantitative autoradiography , 1988, Neuroscience Letters.

[33]  J. Järv,et al.  Substrate specificity of protein kinase C studied with peptides containing D-amino acid residues. , 1993, Journal of biochemistry.